Literature DB >> 12403634

A circularly permuted myoglobin possesses a folded structure and ligand binding similar to those of the wild-type protein but with a reduced thermodynamic stability.

Anna L Fishburn1, Jennifer R Keeffe, Alexei V Lissounov, David H Peyton, Spencer J Anthony-Cahill.   

Abstract

A circular permutein of sperm whale myoglobin in which the G helix is C-terminal, the H helix is N-terminal, and 16 amino acids link the H helix to the A helix has been expressed in Escherichia coli. The permutein sequence begins with Gly121 (using the numbering scheme for the wild-type protein) and terminates with Pro120. The ligand binding function of the permutein was assayed using stopped-flow methods and shown to be essentially identical to that of the wild-type protein. In addition, one- and two-dimensional NMR studies of the cyanomet isoform of the permutein show a nativelike structure with a heme binding pocket very similar to that of the wild-type myoglobin. Although the structure and function of the permutein resemble those of the wild-type myoglobin, the permutein is less stable to chemical denaturation by 5.2 kcal/mol.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12403634     DOI: 10.1021/bi026404g

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  2 in total

1.  The relationship between chain connectivity and domain stability in the equilibrium and kinetic folding mechanisms of dihydrofolate reductase from E.coli.

Authors:  Anna-Karin E Svensson; Jill A Zitzewitz; C Robert Matthews; Virginia F Smith
Journal:  Protein Eng Des Sel       Date:  2006-02-01       Impact factor: 1.650

2.  Coexpression of human alpha- and circularly permuted beta-globins yields a hemoglobin with normal R state but modified T state properties.

Authors:  Anna L Asmundson; Alexandria M Taber; Adella van der Walde; Danielle H Lin; John S Olson; Spencer J Anthony-Cahill
Journal:  Biochemistry       Date:  2009-06-16       Impact factor: 3.162

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.